
Sign up to save your podcasts
Or
According to the U.S. Department of Justice, pharmaceutical giant Biogen will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs. The settlement resolves a lawsuit filed and litigated by former Biogen employee Michael Bawduniak against Biogen under the qui tam or whistleblower provisions of the federal False Claims Act. Famed whistleblower Mary Inman will report this story during the next live edition of Monitor Mondays. Inman, reporting from her London office, is expected to provide details on the settlement.
Other segments will include these instantly recognizable broadcast segments:
4.5
2323 ratings
According to the U.S. Department of Justice, pharmaceutical giant Biogen will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs. The settlement resolves a lawsuit filed and litigated by former Biogen employee Michael Bawduniak against Biogen under the qui tam or whistleblower provisions of the federal False Claims Act. Famed whistleblower Mary Inman will report this story during the next live edition of Monitor Mondays. Inman, reporting from her London office, is expected to provide details on the settlement.
Other segments will include these instantly recognizable broadcast segments:
38,713 Listeners
90,949 Listeners
38,189 Listeners
32,291 Listeners
22,074 Listeners
496 Listeners
3,336 Listeners
111,917 Listeners
56,231 Listeners
478 Listeners
69,085 Listeners
39 Listeners
58 Listeners
184 Listeners
391 Listeners